<DOC>
	<DOCNO>NCT00130429</DOCNO>
	<brief_summary>The purpose study assess effect PYM50028 administer daily 12 week memory faculty subject dementia due Alzheimer 's disease .</brief_summary>
	<brief_title>Safety Effect Memory PYM50028 Mild Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>At least 50 year age Diagnosis possible probable Alzheimer 's disease Mini mental state examination score least 16 Good understand write verbal English A recent head scan consistent diagnosis Alzheimer 's disease Recent history clinical evidence significant neurological disease dementia due Alzheimer 's disease Known another condition associate dementia Use psychotropic medication within previous 4 week ( exclude cholinesterase inhibitor , selective serotonin reuptake inhibitor venlafaxine ) Hormone replacement therapy start change within previous 6 month Received investigational drug within previous 12 week</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>dementia</keyword>
	<keyword>memory</keyword>
	<keyword>Hopkins verbal learning test</keyword>
	<keyword>pair associate learn</keyword>
</DOC>